Advertisement

Index by author

June 01, 1993; Volume 265,Issue 3

A

  1. Ahmed, S S

    1. Adrenochrome reaction implicates oxygen radicals in metabolism of cyclosporine A and FK-506 in rat and human liver microsomes.
      S S Ahmed, H W Strobel, K L Napoli and J Grevel
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1047-1054;

  2. Albuquerque, E X

    1. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes.
      M Alkondon and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1455-1473;
    2. Identification and functional characterization of a new agonist site on nicotinic acetylcholine receptors of cultured hippocampal neurons.
      E F Pereira, S Reinhardt-Maelicke, A Schrattenholz, A Maelicke and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1474-1491;

  3. Aldershvile, J

    1. N-acetylcysteine inhibits angiotensin converting enzyme in vivo.
      S Boesgaard, J Aldershvile, H E Poulsen, S Christensen, H Dige-Petersen and J Giese
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1239-1244;

  4. Aldrich, P E

    1. Pharmacology of 2-amino-1,4-dihydro-4-(2-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butylsulfinyl]phenyl)-6-methyl-5-nitro-3-pyridine carboxylic acid methyl ester (XB513), a novel calcium agonist with alpha-1 adrenergic receptor antagonistic.
      P C Wong, P E Aldrich, A T Chiu, R A Earl, S D Hart, A L Johnson, P Ma, D E McCall, W A Price and R D Smith
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1088-1095;

  5. Alkondon, M

    1. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes.
      M Alkondon and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1455-1473;

  6. Anderson, B

    1. Comparison of the in vitro and in vivo cardiovascular effects of two structurally distinct Ca++ channel activators, BAY K 8644 and FPL 64176.
      D Rampe, B Anderson, V Rapien-Pryor, T Li and R C Dage
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1125-1130;

  7. Anderson, D K

    1. The inotropic and beta blocking effects of a chimeric molecule that putatively inhibits both type III phosphodiesterase and beta adrenoceptors in anesthetized dogs.
      J E Shaffer, M K Grizzle, D K Anderson and T N Wheeler
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1105-1112;

  8. Appalsamy, M

    1. Effects of nicotine on brain stem mechanisms of cardiovascular control.
      C J Tseng, M Appalsamy, D Robertson and R Mosqueda-Garcia
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1511-1518;

  9. Appleyard, S M

    1. Antinociceptive profile of biphalin, a dimeric enkephalin analog.
      P J Horan, A Mattia, E J Bilsky, S Weber, T P Davis, H I Yamamura, E Malatynska, S M Appleyard, J Slaninova and A Misicka
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1446-1454;

  10. Ardaillou, R

    1. Intrinsic properties of the nonpeptide angiotensin II antagonist losartan in glomeruli and mesangial cells at high concentrations.
      D Chansel, L Badre, S Czekalski, S Vandermeersch, J Cambar and R Ardaillou
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1534-1543;

  11. Audia, J E

    1. Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines.
      D L Nelson, V L Lucaites, J E Audia, J S Nissen and D B Wainscott
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1272-1279;

  12. Auerbach, S B

    1. Acute uptake inhibition increases extracellular serotonin in the rat forebrain.
      J J Rutter and S B Auerbach
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1319-1324;

B

  1. Baba, N

    1. Structure-activity relationship for D-ring derivatives of grayanotoxin in the squid giant axon.
      M Yakehiro, S Yamamoto, N Baba, S Nakajima, J Iwasa and I Seyama
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1328-1332;

  2. Badre, L

    1. Intrinsic properties of the nonpeptide angiotensin II antagonist losartan in glomeruli and mesangial cells at high concentrations.
      D Chansel, L Badre, S Czekalski, S Vandermeersch, J Cambar and R Ardaillou
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1534-1543;

  3. Bakshi, V P

    1. Feeding induced by opioid stimulation of the ventral striatum: role of opiate receptor subtypes.
      V P Bakshi and A E Kelley
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1253-1260;

  4. Banerjee, S P

    1. Acute administration of haloperidol enhances dopaminergic transmission.
      T I Lidsky and S P Banerjee
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1193-1198;

  5. Beaudry, C

    1. Characterization of indolidan- and rolipram-sensitive cyclic nucleotide phosphodiesterases in canine and human cardiac microsomal fractions.
      C Lugnier, B Muller, A Le Bec, C Beaudry and E Rousseau
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1142-1151;

  6. Bennett, E H

    1. Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone.
      D T Lysle, M E Coussons, V J Watts, E H Bennett and L A Dykstra
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1071-1078;

  7. Berg, R A

    1. Dobutamine pharmacokinetics and pharmacodynamics in normal children and adolescents.
      R A Berg, J F Padbury, R L Donnerstein, S E Klewer and J J Hutter
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1232-1238;

  8. Bergman, J

    1. Modification of the behavioral effects of the selective dopamine D2 agonist (+)-4-propyl-9-hydroxynaphthoxazine by dopamine antagonists in monkeys.
      S Rosenzweig-Lipson and J Bergman
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1039-1046;

  9. Bevan, D R

    1. Speed of action of various muscle relaxants at the neuromuscular junction binding vs. buffering hypothesis.
      M I Glavinovic, J C Law Min, L Kapural, F Donati and D R Bevan
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1181-1186;

  10. Bijlsma, J A

    1. Indomethacin- and desamino-8-D-arginine vasopressin-induced lithium reabsorption is not amiloride sensitive in humans.
      J A Bijlsma, H A Koomans, W H Boer, E J Dorhout Mees and H J van Rijn
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1267-1271;

  11. Bilsky, E J

    1. Antinociceptive profile of biphalin, a dimeric enkephalin analog.
      P J Horan, A Mattia, E J Bilsky, S Weber, T P Davis, H I Yamamura, E Malatynska, S M Appleyard, J Slaninova and A Misicka
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1446-1454;

  12. Blouin, R A

    1. Effect of genetic obesity and phenobarbital treatment on the hepatic conjugation pathways.
      I P Chaudhary, S Tuntaterdtum, P J McNamara, L W Robertson and R A Blouin
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1333-1338;

  13. Boer, W H

    1. Indomethacin- and desamino-8-D-arginine vasopressin-induced lithium reabsorption is not amiloride sensitive in humans.
      J A Bijlsma, H A Koomans, W H Boer, E J Dorhout Mees and H J van Rijn
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1267-1271;

  14. Boesgaard, S

    1. N-acetylcysteine inhibits angiotensin converting enzyme in vivo.
      S Boesgaard, J Aldershvile, H E Poulsen, S Christensen, H Dige-Petersen and J Giese
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1239-1244;

  15. Brady, H R

    1. Differential actions of cisplatin on renal proximal tubule and inner medullary collecting duct cells.
      H R Brady, M L Zeidel, B C Kone, G Giebisch and S R Gullans
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1421-1428;

  16. Brandsgaard, R R

    1. Behavioral pharmacology of NPC 17742, a competitive N-methyl-D-aspartate (NMDA) antagonist.
      J Willetts, D B Clissold, T L Hartman, R R Brandsgaard, G S Hamilton and J W Ferkany
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1055-1062;

C

  1. Calder, J A

    1. Ion channel involvement in the acute vascular effects of thiazide diuretics and related compounds.
      J A Calder, M Schachter and P S Sever
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1175-1180;

  2. Cambar, J

    1. Intrinsic properties of the nonpeptide angiotensin II antagonist losartan in glomeruli and mesangial cells at high concentrations.
      D Chansel, L Badre, S Czekalski, S Vandermeersch, J Cambar and R Ardaillou
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1534-1543;

  3. Castle, N A

    1. Characterization of 4-aminopyridine block of the transient outward K+ current in adult rat ventricular myocytes.
      N A Castle and M T Slawsky
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1450-1459;

  4. Chansel, D

    1. Intrinsic properties of the nonpeptide angiotensin II antagonist losartan in glomeruli and mesangial cells at high concentrations.
      D Chansel, L Badre, S Czekalski, S Vandermeersch, J Cambar and R Ardaillou
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1534-1543;

  5. Chaudhary, I P

    1. Effect of genetic obesity and phenobarbital treatment on the hepatic conjugation pathways.
      I P Chaudhary, S Tuntaterdtum, P J McNamara, L W Robertson and R A Blouin
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1333-1338;

  6. Chemtob, S

    1. Endothelium- and beta-2 adrenoceptor-independent relaxation of rat aorta by tyramine and certain other phenylethylamines.
      D R Varma and S Chemtob
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1096-1104;

  7. Chen, Y J

    1. Modulation of cardiac performance by amiloride and several selected derivatives of amiloride.
      G N Pierce, W C Cole, K Liu, H Massaeli, T G Maddaford, Y J Chen, C D McPherson, S Jain and D Sontag
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1280-1291;

  8. Cherry, W F

    1. Stereoselectivity in glutathione conjugation and amidase-catalyzed hydrolysis of the 2-bromoisovalerylurea enantiomers in the single-pass perfused rat liver.
      M Polhuijs, I Gasinska, W F Cherry, G J Mulder and K S Pang
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1406-1412;

  9. Chiu, A T

    1. Pharmacology of 2-amino-1,4-dihydro-4-(2-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butylsulfinyl]phenyl)-6-methyl-5-nitro-3-pyridine carboxylic acid methyl ester (XB513), a novel calcium agonist with alpha-1 adrenergic receptor antagonistic.
      P C Wong, P E Aldrich, A T Chiu, R A Earl, S D Hart, A L Johnson, P Ma, D E McCall, W A Price and R D Smith
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1088-1095;

  10. Christensen, S

    1. N-acetylcysteine inhibits angiotensin converting enzyme in vivo.
      S Boesgaard, J Aldershvile, H E Poulsen, S Christensen, H Dige-Petersen and J Giese
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1239-1244;

  11. Cieslinski, L B

    1. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle.
      T J Torphy, B J Undem, L B Cieslinski, M A Luttmann, M L Reeves and D W Hay
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1213-1223;

  12. Clissold, D B

    1. Behavioral pharmacology of NPC 17742, a competitive N-methyl-D-aspartate (NMDA) antagonist.
      J Willetts, D B Clissold, T L Hartman, R R Brandsgaard, G S Hamilton and J W Ferkany
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1055-1062;

  13. Cohen, M M

    1. Endothelin differentially affects rat gastric longitudinal and circular smooth muscle.
      J Fulginiti, M M Cohen and R S Moreland
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1413-1420;

  14. Colbert, J C

    1. The oral antihypertensive activity of the methylated derivatives of phenyl-2-aminoethyl sulfide.
      S H Pollock, M I Reichbaum, J C Colbert, P A Husain, J M Holbrook, A A Ogonowski, J S Khlief and S W May
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1113-1117;

  15. Cole, W C

    1. Modulation of cardiac performance by amiloride and several selected derivatives of amiloride.
      G N Pierce, W C Cole, K Liu, H Massaeli, T G Maddaford, Y J Chen, C D McPherson, S Jain and D Sontag
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1280-1291;

  16. Coussons, M E

    1. Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone.
      D T Lysle, M E Coussons, V J Watts, E H Bennett and L A Dykstra
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1071-1078;

  17. Crofton, K M

    1. Administration of 3,3'-iminodipropionitrile to the rat results in region-dependent damage to the central nervous system at levels above the brain stem.
      J Llorens, K M Crofton and J P O'Callaghan
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1492-1498;

  18. Cruz, S L

    1. Quantitative analysis of concentration-response curves for precipitated abstinence responses in the opiate-dependent guinea pig ileum.
      S L Cruz, L A Salazar, A Fernández-Guasti and J E Villarreal
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1519-1526;

  19. Czekalski, S

    1. Intrinsic properties of the nonpeptide angiotensin II antagonist losartan in glomeruli and mesangial cells at high concentrations.
      D Chansel, L Badre, S Czekalski, S Vandermeersch, J Cambar and R Ardaillou
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1534-1543;

D

  1. Dage, R C

    1. Comparison of the in vitro and in vivo cardiovascular effects of two structurally distinct Ca++ channel activators, BAY K 8644 and FPL 64176.
      D Rampe, B Anderson, V Rapien-Pryor, T Li and R C Dage
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1125-1130;

  2. Davis, T P

    1. Antinociceptive profile of biphalin, a dimeric enkephalin analog.
      P J Horan, A Mattia, E J Bilsky, S Weber, T P Davis, H I Yamamura, E Malatynska, S M Appleyard, J Slaninova and A Misicka
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1446-1454;

  3. Delansorne, R

    1. Progesterone and mifepristone modify principally the responses of circular myometrium to oxytocin in preparturient rats: comparison with responses to acetylcholine and to calcium.
      A el Alj, N Winer, H Lallaoui, R Delansorne, F Ferre and G Germain
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1205-1212;

  4. Dige-Petersen, H

    1. N-acetylcysteine inhibits angiotensin converting enzyme in vivo.
      S Boesgaard, J Aldershvile, H E Poulsen, S Christensen, H Dige-Petersen and J Giese
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1239-1244;

  5. Dikshit, M

    1. Pulmonary thromboembolism-induced alterations in nitric oxide release from rat circulating neutrophils.
      M Dikshit, R Kumari and R C Srimal
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1369-1373;

  6. Domino, E F

    1. Relative potency and efficacy of some dopamine agonists with varying selectivities for D1 and D2 receptors in MPTP-induced hemiparkinsonian monkeys.
      E F Domino and J Sheng
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1387-1391;

  7. Donati, F

    1. Speed of action of various muscle relaxants at the neuromuscular junction binding vs. buffering hypothesis.
      M I Glavinovic, J C Law Min, L Kapural, F Donati and D R Bevan
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1181-1186;

  8. Donnerstein, R L

    1. Dobutamine pharmacokinetics and pharmacodynamics in normal children and adolescents.
      R A Berg, J F Padbury, R L Donnerstein, S E Klewer and J J Hutter
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1232-1238;

  9. Dorhout Mees, E J

    1. Indomethacin- and desamino-8-D-arginine vasopressin-induced lithium reabsorption is not amiloride sensitive in humans.
      J A Bijlsma, H A Koomans, W H Boer, E J Dorhout Mees and H J van Rijn
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1267-1271;

  10. Dretchen, K L

    1. Acute effects of calcitonin gene-related peptide on the mechanical and electrical responses of the rat hemidiaphragm.
      N W Fleming, B K Lewis, D A White and K L Dretchen
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1199-1204;

  11. Dykstra, L A

    1. Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone.
      D T Lysle, M E Coussons, V J Watts, E H Bennett and L A Dykstra
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1071-1078;
    2. Evidence for beta adrenergic receptor involvement in the immunomodulatory effects of morphine.
      K Fecho, L A Dykstra and D T Lysle
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1079-1087;

E

  1. Earl, R A

    1. Pharmacology of 2-amino-1,4-dihydro-4-(2-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butylsulfinyl]phenyl)-6-methyl-5-nitro-3-pyridine carboxylic acid methyl ester (XB513), a novel calcium agonist with alpha-1 adrenergic receptor antagonistic.
      P C Wong, P E Aldrich, A T Chiu, R A Earl, S D Hart, A L Johnson, P Ma, D E McCall, W A Price and R D Smith
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1088-1095;

  2. el Alj, A

    1. Progesterone and mifepristone modify principally the responses of circular myometrium to oxytocin in preparturient rats: comparison with responses to acetylcholine and to calcium.
      A el Alj, N Winer, H Lallaoui, R Delansorne, F Ferre and G Germain
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1205-1212;

  3. el Amrani, A I

    1. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
      I Pham, W Gonzalez, A I el Amrani, M C Fournié-Zaluski, M Philippe, I Laboulandine, B P Roques and J B Michel
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1339-1347;

  4. Endoh, M

    1. On the mechanism of action of the beta-1 partial agonist denopamine in regulation of myocardial contractility: effects on myocardial alpha adrenoceptors and intracellular Ca++ transients.
      M Kohi, I Norota, M Takanashi and M Endoh
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1292-1300;

  5. Evans, S M

    1. Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: antagonism and precipitated withdrawal.
      R R Griffiths, S M Evans, J J Guarino, J D Roache, W R Furman, I Liebson and E M Schwam
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1163-1174;

  6. Ewing, R W

    1. The gastrin/cholecystokinin-B receptor antagonist L-365,260 reduces basal acid secretion and prevents gastrointestinal damage induced by aspirin, ethanol and cysteamine in the rat.
      C E Pendley, L R Fitzpatrick, R W Ewing, B F Molino and G E Martin
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1348-1354;

F

  1. Fecho, K

    1. Evidence for beta adrenergic receptor involvement in the immunomodulatory effects of morphine.
      K Fecho, L A Dykstra and D T Lysle
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1079-1087;

  2. Ferkany, J W

    1. Behavioral pharmacology of NPC 17742, a competitive N-methyl-D-aspartate (NMDA) antagonist.
      J Willetts, D B Clissold, T L Hartman, R R Brandsgaard, G S Hamilton and J W Ferkany
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1055-1062;

  3. Fernández-Guasti, A

    1. Quantitative analysis of concentration-response curves for precipitated abstinence responses in the opiate-dependent guinea pig ileum.
      S L Cruz, L A Salazar, A Fernández-Guasti and J E Villarreal
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1519-1526;

  4. Ferre, F

    1. Progesterone and mifepristone modify principally the responses of circular myometrium to oxytocin in preparturient rats: comparison with responses to acetylcholine and to calcium.
      A el Alj, N Winer, H Lallaoui, R Delansorne, F Ferre and G Germain
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1205-1212;

  5. Fink, G D

    1. Losartan prevents salt-induced hypertension in reduced renal mass rats.
      N L Kanagy and G D Fink
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1131-1136;

  6. Finn, D A

    1. The influence of estrus cycle on neurosteroid potency at the gamma-aminobutyric acidA receptor complex.
      D A Finn and K W Gee
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1374-1379;

  7. Fitzpatrick, L R

    1. The gastrin/cholecystokinin-B receptor antagonist L-365,260 reduces basal acid secretion and prevents gastrointestinal damage induced by aspirin, ethanol and cysteamine in the rat.
      C E Pendley, L R Fitzpatrick, R W Ewing, B F Molino and G E Martin
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1348-1354;

  8. Fleming, N W

    1. Acute effects of calcitonin gene-related peptide on the mechanical and electrical responses of the rat hemidiaphragm.
      N W Fleming, B K Lewis, D A White and K L Dretchen
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1199-1204;

  9. Flezar, M

    1. P2-purinergic receptors in human breast tumor cells: coupling of intracellular calcium signaling to anion secretion.
      M Flezar and S Heisler
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1499-1510;

  10. Fournié-Zaluski, M C

    1. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
      I Pham, W Gonzalez, A I el Amrani, M C Fournié-Zaluski, M Philippe, I Laboulandine, B P Roques and J B Michel
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1339-1347;

  11. Fournier, D J

    1. Characterization of methotrexate elimination and interaction with indomethacin and flurbiprofen in the isolated perfused rat kidney.
      P Statkevich, D J Fournier and K R Sweeney
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1118-1124;

  12. Fujimoto, J M

    1. Pentobarbital administered intracerebroventricularly antagonizes morphine-induced antinociception in mice.
      F S Wang and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1361-1368;

  13. Fulginiti, J

    1. Endothelin differentially affects rat gastric longitudinal and circular smooth muscle.
      J Fulginiti, M M Cohen and R S Moreland
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1413-1420;

  14. Furman, W R

    1. Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: antagonism and precipitated withdrawal.
      R R Griffiths, S M Evans, J J Guarino, J D Roache, W R Furman, I Liebson and E M Schwam
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1163-1174;

G

  1. Gasinska, I

    1. Stereoselectivity in glutathione conjugation and amidase-catalyzed hydrolysis of the 2-bromoisovalerylurea enantiomers in the single-pass perfused rat liver.
      M Polhuijs, I Gasinska, W F Cherry, G J Mulder and K S Pang
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1406-1412;

  2. Gee, K W

    1. The influence of estrus cycle on neurosteroid potency at the gamma-aminobutyric acidA receptor complex.
      D A Finn and K W Gee
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1374-1379;

  3. Germain, G

    1. Progesterone and mifepristone modify principally the responses of circular myometrium to oxytocin in preparturient rats: comparison with responses to acetylcholine and to calcium.
      A el Alj, N Winer, H Lallaoui, R Delansorne, F Ferre and G Germain
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1205-1212;

  4. Giachetti, A

    1. Tachykinins and reflexly evoked atropine-resistant motility in the guinea pig colon in vivo.
      S Giuliani, A Lecci, A Giachetti and C A Maggi
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1224-1231;

  5. Giebisch, G

    1. Differential actions of cisplatin on renal proximal tubule and inner medullary collecting duct cells.
      H R Brady, M L Zeidel, B C Kone, G Giebisch and S R Gullans
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1421-1428;

  6. Giese, J

    1. N-acetylcysteine inhibits angiotensin converting enzyme in vivo.
      S Boesgaard, J Aldershvile, H E Poulsen, S Christensen, H Dige-Petersen and J Giese
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1239-1244;

  7. Giuliani, S

    1. Tachykinins and reflexly evoked atropine-resistant motility in the guinea pig colon in vivo.
      S Giuliani, A Lecci, A Giachetti and C A Maggi
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1224-1231;

  8. Glavinovic, M I

    1. Speed of action of various muscle relaxants at the neuromuscular junction binding vs. buffering hypothesis.
      M I Glavinovic, J C Law Min, L Kapural, F Donati and D R Bevan
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1181-1186;

  9. Gonzalez, W

    1. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
      I Pham, W Gonzalez, A I el Amrani, M C Fournié-Zaluski, M Philippe, I Laboulandine, B P Roques and J B Michel
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1339-1347;

  10. Grevel, J

    1. Adrenochrome reaction implicates oxygen radicals in metabolism of cyclosporine A and FK-506 in rat and human liver microsomes.
      S S Ahmed, H W Strobel, K L Napoli and J Grevel
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1047-1054;

  11. Griffiths, R R

    1. Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: antagonism and precipitated withdrawal.
      R R Griffiths, S M Evans, J J Guarino, J D Roache, W R Furman, I Liebson and E M Schwam
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1163-1174;

  12. Grizzle, M K

    1. The inotropic and beta blocking effects of a chimeric molecule that putatively inhibits both type III phosphodiesterase and beta adrenoceptors in anesthetized dogs.
      J E Shaffer, M K Grizzle, D K Anderson and T N Wheeler
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1105-1112;

  13. Guarino, J J

    1. Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: antagonism and precipitated withdrawal.
      R R Griffiths, S M Evans, J J Guarino, J D Roache, W R Furman, I Liebson and E M Schwam
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1163-1174;

  14. Gullans, S R

    1. Differential actions of cisplatin on renal proximal tubule and inner medullary collecting duct cells.
      H R Brady, M L Zeidel, B C Kone, G Giebisch and S R Gullans
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1421-1428;

  15. Gunnell, M

    1. Dose- and time-dependent changes in phencyclidine metabolite covalent binding in rats and the possible role of CYP2D1.
      S M Owens, M Gunnell, E M Laurenzana and J L Valentine
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1261-1266;

H

  1. Halaka, N N

    1. 8-(Diethylamino)-octyl-3,4,5-trimethoxybenzoate inhibits cromakalim-induced 86Rb efflux from the rat aorta.
      N J Lodge and N N Halaka
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1399-1405;

  2. Hamilton, G S

    1. Behavioral pharmacology of NPC 17742, a competitive N-methyl-D-aspartate (NMDA) antagonist.
      J Willetts, D B Clissold, T L Hartman, R R Brandsgaard, G S Hamilton and J W Ferkany
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1055-1062;

  3. Hanano, M

    1. Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats.
      K Sathirakul, H Suzuki, K Yasuda, M Hanano, O Tagaya, T Horie and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1301-1312;

  4. Harris, B

    1. Neurochemical actions of inhalational anesthetics at the GABAA receptor complex.
      B Harris, G Wong and P Skolnick
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1392-1398;

  5. Hart, S D

    1. Pharmacology of 2-amino-1,4-dihydro-4-(2-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butylsulfinyl]phenyl)-6-methyl-5-nitro-3-pyridine carboxylic acid methyl ester (XB513), a novel calcium agonist with alpha-1 adrenergic receptor antagonistic.
      P C Wong, P E Aldrich, A T Chiu, R A Earl, S D Hart, A L Johnson, P Ma, D E McCall, W A Price and R D Smith
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1088-1095;

  6. Hartman, T L

    1. Behavioral pharmacology of NPC 17742, a competitive N-methyl-D-aspartate (NMDA) antagonist.
      J Willetts, D B Clissold, T L Hartman, R R Brandsgaard, G S Hamilton and J W Ferkany
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1055-1062;

  7. Hay, D W

    1. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle.
      T J Torphy, B J Undem, L B Cieslinski, M A Luttmann, M L Reeves and D W Hay
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1213-1223;

  8. Hayashi, S

    1. Ionic mechanism of minoxidil sulfate-induced shortening of action potential durations in guinea pig ventricular myocytes.
      S Hayashi, M Horie and Y Okada
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1527-1533;

  9. Heisler, S

    1. P2-purinergic receptors in human breast tumor cells: coupling of intracellular calcium signaling to anion secretion.
      M Flezar and S Heisler
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1499-1510;

  10. Henriksen, S J

    1. Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats.
      S S Negus, S J Henriksen, A Mattox, G W Pasternak, P S Portoghese, A E Takemori, M B Weinger and G F Koob
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1245-1252;

  11. Holbrook, J M

    1. The oral antihypertensive activity of the methylated derivatives of phenyl-2-aminoethyl sulfide.
      S H Pollock, M I Reichbaum, J C Colbert, P A Husain, J M Holbrook, A A Ogonowski, J S Khlief and S W May
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1113-1117;

  12. Horan, P J

    1. Antinociceptive profile of biphalin, a dimeric enkephalin analog.
      P J Horan, A Mattia, E J Bilsky, S Weber, T P Davis, H I Yamamura, E Malatynska, S M Appleyard, J Slaninova and A Misicka
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1446-1454;

  13. Horie, M

    1. Ionic mechanism of minoxidil sulfate-induced shortening of action potential durations in guinea pig ventricular myocytes.
      S Hayashi, M Horie and Y Okada
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1527-1533;

  14. Horie, S

    1. Inhibition of gastric acid secretion in vivo and in vitro by an inhibitor of Cl(-)-HCO3- exchanger, 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid.
      S Horie, S Yano and K Watanabe
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1313-1318;

  15. Horie, T

    1. Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats.
      K Sathirakul, H Suzuki, K Yasuda, M Hanano, O Tagaya, T Horie and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1301-1312;

  16. Husain, P A

    1. The oral antihypertensive activity of the methylated derivatives of phenyl-2-aminoethyl sulfide.
      S H Pollock, M I Reichbaum, J C Colbert, P A Husain, J M Holbrook, A A Ogonowski, J S Khlief and S W May
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1113-1117;

  17. Hutter, J J

    1. Dobutamine pharmacokinetics and pharmacodynamics in normal children and adolescents.
      R A Berg, J F Padbury, R L Donnerstein, S E Klewer and J J Hutter
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1232-1238;

I

  1. Imai, S

    1. Putative, selective inhibitors of sarcoplasmic reticulum Ca+(+)-pump ATPase inhibit relaxation by nitroglycerin and atrial natriuretic factor of the rabbit aorta contracted by phenylephrine.
      D L Luo, M Nakazawa, T Ishibashi, K Kato and S Imai
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1187-1192;

  2. Ishibashi, T

    1. Putative, selective inhibitors of sarcoplasmic reticulum Ca+(+)-pump ATPase inhibit relaxation by nitroglycerin and atrial natriuretic factor of the rabbit aorta contracted by phenylephrine.
      D L Luo, M Nakazawa, T Ishibashi, K Kato and S Imai
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1187-1192;

  3. Iwasa, J

    1. Structure-activity relationship for D-ring derivatives of grayanotoxin in the squid giant axon.
      M Yakehiro, S Yamamoto, N Baba, S Nakajima, J Iwasa and I Seyama
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1328-1332;

J

  1. Jain, S

    1. Modulation of cardiac performance by amiloride and several selected derivatives of amiloride.
      G N Pierce, W C Cole, K Liu, H Massaeli, T G Maddaford, Y J Chen, C D McPherson, S Jain and D Sontag
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1280-1291;

  2. Johnson, A L

    1. Pharmacology of 2-amino-1,4-dihydro-4-(2-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butylsulfinyl]phenyl)-6-methyl-5-nitro-3-pyridine carboxylic acid methyl ester (XB513), a novel calcium agonist with alpha-1 adrenergic receptor antagonistic.
      P C Wong, P E Aldrich, A T Chiu, R A Earl, S D Hart, A L Johnson, P Ma, D E McCall, W A Price and R D Smith
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1088-1095;

K

  1. Kanagy, N L

    1. Losartan prevents salt-induced hypertension in reduced renal mass rats.
      N L Kanagy and G D Fink
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1131-1136;

  2. Kapural, L

    1. Speed of action of various muscle relaxants at the neuromuscular junction binding vs. buffering hypothesis.
      M I Glavinovic, J C Law Min, L Kapural, F Donati and D R Bevan
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1181-1186;

  3. Kato, K

    1. Putative, selective inhibitors of sarcoplasmic reticulum Ca+(+)-pump ATPase inhibit relaxation by nitroglycerin and atrial natriuretic factor of the rabbit aorta contracted by phenylephrine.
      D L Luo, M Nakazawa, T Ishibashi, K Kato and S Imai
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1187-1192;

  4. Kelley, A E

    1. Feeding induced by opioid stimulation of the ventral striatum: role of opiate receptor subtypes.
      V P Bakshi and A E Kelley
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1253-1260;

  5. Khlief, J S

    1. The oral antihypertensive activity of the methylated derivatives of phenyl-2-aminoethyl sulfide.
      S H Pollock, M I Reichbaum, J C Colbert, P A Husain, J M Holbrook, A A Ogonowski, J S Khlief and S W May
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1113-1117;

  6. Klewer, S E

    1. Dobutamine pharmacokinetics and pharmacodynamics in normal children and adolescents.
      R A Berg, J F Padbury, R L Donnerstein, S E Klewer and J J Hutter
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1232-1238;

  7. Kohi, M

    1. On the mechanism of action of the beta-1 partial agonist denopamine in regulation of myocardial contractility: effects on myocardial alpha adrenoceptors and intracellular Ca++ transients.
      M Kohi, I Norota, M Takanashi and M Endoh
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1292-1300;

  8. Kone, B C

    1. Differential actions of cisplatin on renal proximal tubule and inner medullary collecting duct cells.
      H R Brady, M L Zeidel, B C Kone, G Giebisch and S R Gullans
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1421-1428;

  9. Koob, G F

    1. Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats.
      S S Negus, S J Henriksen, A Mattox, G W Pasternak, P S Portoghese, A E Takemori, M B Weinger and G F Koob
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1245-1252;

  10. Koomans, H A

    1. Indomethacin- and desamino-8-D-arginine vasopressin-induced lithium reabsorption is not amiloride sensitive in humans.
      J A Bijlsma, H A Koomans, W H Boer, E J Dorhout Mees and H J van Rijn
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1267-1271;

  11. Kumari, R

    1. Pulmonary thromboembolism-induced alterations in nitric oxide release from rat circulating neutrophils.
      M Dikshit, R Kumari and R C Srimal
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1369-1373;

L

  1. Laboulandine, I

    1. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
      I Pham, W Gonzalez, A I el Amrani, M C Fournié-Zaluski, M Philippe, I Laboulandine, B P Roques and J B Michel
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1339-1347;

  2. Lallaoui, H

    1. Progesterone and mifepristone modify principally the responses of circular myometrium to oxytocin in preparturient rats: comparison with responses to acetylcholine and to calcium.
      A el Alj, N Winer, H Lallaoui, R Delansorne, F Ferre and G Germain
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1205-1212;

  3. Laurenzana, E M

    1. Dose- and time-dependent changes in phencyclidine metabolite covalent binding in rats and the possible role of CYP2D1.
      S M Owens, M Gunnell, E M Laurenzana and J L Valentine
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1261-1266;

  4. Law Min, J C

    1. Speed of action of various muscle relaxants at the neuromuscular junction binding vs. buffering hypothesis.
      M I Glavinovic, J C Law Min, L Kapural, F Donati and D R Bevan
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1181-1186;

  5. Layer, R T

    1. Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid.
      G Nowak, R Trullas, R T Layer, P Skolnick and I A Paul
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1380-1386;

  6. Le Bec, A

    1. Characterization of indolidan- and rolipram-sensitive cyclic nucleotide phosphodiesterases in canine and human cardiac microsomal fractions.
      C Lugnier, B Muller, A Le Bec, C Beaudry and E Rousseau
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1142-1151;

  7. Lecci, A

    1. Tachykinins and reflexly evoked atropine-resistant motility in the guinea pig colon in vivo.
      S Giuliani, A Lecci, A Giachetti and C A Maggi
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1224-1231;

  8. Lewis, B K

    1. Acute effects of calcitonin gene-related peptide on the mechanical and electrical responses of the rat hemidiaphragm.
      N W Fleming, B K Lewis, D A White and K L Dretchen
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1199-1204;

  9. Li, T

    1. Comparison of the in vitro and in vivo cardiovascular effects of two structurally distinct Ca++ channel activators, BAY K 8644 and FPL 64176.
      D Rampe, B Anderson, V Rapien-Pryor, T Li and R C Dage
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1125-1130;

  10. Lidsky, T I

    1. Acute administration of haloperidol enhances dopaminergic transmission.
      T I Lidsky and S P Banerjee
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1193-1198;

  11. Liebson, I

    1. Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: antagonism and precipitated withdrawal.
      R R Griffiths, S M Evans, J J Guarino, J D Roache, W R Furman, I Liebson and E M Schwam
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1163-1174;

  12. Liu, K

    1. Modulation of cardiac performance by amiloride and several selected derivatives of amiloride.
      G N Pierce, W C Cole, K Liu, H Massaeli, T G Maddaford, Y J Chen, C D McPherson, S Jain and D Sontag
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1280-1291;

  13. Llorens, J

    1. Administration of 3,3'-iminodipropionitrile to the rat results in region-dependent damage to the central nervous system at levels above the brain stem.
      J Llorens, K M Crofton and J P O'Callaghan
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1492-1498;

  14. Lodge, N J

    1. 8-(Diethylamino)-octyl-3,4,5-trimethoxybenzoate inhibits cromakalim-induced 86Rb efflux from the rat aorta.
      N J Lodge and N N Halaka
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1399-1405;

  15. Lucaites, V L

    1. Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines.
      D L Nelson, V L Lucaites, J E Audia, J S Nissen and D B Wainscott
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1272-1279;

  16. Lugnier, C

    1. Characterization of indolidan- and rolipram-sensitive cyclic nucleotide phosphodiesterases in canine and human cardiac microsomal fractions.
      C Lugnier, B Muller, A Le Bec, C Beaudry and E Rousseau
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1142-1151;

  17. Luo, D L

    1. Putative, selective inhibitors of sarcoplasmic reticulum Ca+(+)-pump ATPase inhibit relaxation by nitroglycerin and atrial natriuretic factor of the rabbit aorta contracted by phenylephrine.
      D L Luo, M Nakazawa, T Ishibashi, K Kato and S Imai
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1187-1192;

  18. Luttmann, M A

    1. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle.
      T J Torphy, B J Undem, L B Cieslinski, M A Luttmann, M L Reeves and D W Hay
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1213-1223;

  19. Lysle, D T

    1. Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone.
      D T Lysle, M E Coussons, V J Watts, E H Bennett and L A Dykstra
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1071-1078;
    2. Evidence for beta adrenergic receptor involvement in the immunomodulatory effects of morphine.
      K Fecho, L A Dykstra and D T Lysle
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1079-1087;

M

  1. Ma, P

    1. Pharmacology of 2-amino-1,4-dihydro-4-(2-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butylsulfinyl]phenyl)-6-methyl-5-nitro-3-pyridine carboxylic acid methyl ester (XB513), a novel calcium agonist with alpha-1 adrenergic receptor antagonistic.
      P C Wong, P E Aldrich, A T Chiu, R A Earl, S D Hart, A L Johnson, P Ma, D E McCall, W A Price and R D Smith
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1088-1095;

  2. Maddaford, T G

    1. Modulation of cardiac performance by amiloride and several selected derivatives of amiloride.
      G N Pierce, W C Cole, K Liu, H Massaeli, T G Maddaford, Y J Chen, C D McPherson, S Jain and D Sontag
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1280-1291;

  3. Maelicke, A

    1. Identification and functional characterization of a new agonist site on nicotinic acetylcholine receptors of cultured hippocampal neurons.
      E F Pereira, S Reinhardt-Maelicke, A Schrattenholz, A Maelicke and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1474-1491;

  4. Maggi, C A

    1. Tachykinins and reflexly evoked atropine-resistant motility in the guinea pig colon in vivo.
      S Giuliani, A Lecci, A Giachetti and C A Maggi
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1224-1231;

  5. Malatynska, E

    1. Antinociceptive profile of biphalin, a dimeric enkephalin analog.
      P J Horan, A Mattia, E J Bilsky, S Weber, T P Davis, H I Yamamura, E Malatynska, S M Appleyard, J Slaninova and A Misicka
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1446-1454;

  6. Martin, G E

    1. The gastrin/cholecystokinin-B receptor antagonist L-365,260 reduces basal acid secretion and prevents gastrointestinal damage induced by aspirin, ethanol and cysteamine in the rat.
      C E Pendley, L R Fitzpatrick, R W Ewing, B F Molino and G E Martin
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1348-1354;

  7. Martin, W R

    1. Effect of the chronic dose of diazepam on the intensity and characteristics of the precipitated abstinence syndrome in the dog.
      J W Sloan, W R Martin and E Wala
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1152-1162;

  8. Massaeli, H

    1. Modulation of cardiac performance by amiloride and several selected derivatives of amiloride.
      G N Pierce, W C Cole, K Liu, H Massaeli, T G Maddaford, Y J Chen, C D McPherson, S Jain and D Sontag
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1280-1291;

  9. Mattia, A

    1. Antinociceptive profile of biphalin, a dimeric enkephalin analog.
      P J Horan, A Mattia, E J Bilsky, S Weber, T P Davis, H I Yamamura, E Malatynska, S M Appleyard, J Slaninova and A Misicka
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1446-1454;

  10. Mattox, A

    1. Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats.
      S S Negus, S J Henriksen, A Mattox, G W Pasternak, P S Portoghese, A E Takemori, M B Weinger and G F Koob
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1245-1252;

  11. May, S W

    1. The oral antihypertensive activity of the methylated derivatives of phenyl-2-aminoethyl sulfide.
      S H Pollock, M I Reichbaum, J C Colbert, P A Husain, J M Holbrook, A A Ogonowski, J S Khlief and S W May
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1113-1117;

  12. McCall, D E

    1. Pharmacology of 2-amino-1,4-dihydro-4-(2-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butylsulfinyl]phenyl)-6-methyl-5-nitro-3-pyridine carboxylic acid methyl ester (XB513), a novel calcium agonist with alpha-1 adrenergic receptor antagonistic.
      P C Wong, P E Aldrich, A T Chiu, R A Earl, S D Hart, A L Johnson, P Ma, D E McCall, W A Price and R D Smith
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1088-1095;

  13. McNamara, P J

    1. Effect of genetic obesity and phenobarbital treatment on the hepatic conjugation pathways.
      I P Chaudhary, S Tuntaterdtum, P J McNamara, L W Robertson and R A Blouin
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1333-1338;

  14. McPherson, C D

    1. Modulation of cardiac performance by amiloride and several selected derivatives of amiloride.
      G N Pierce, W C Cole, K Liu, H Massaeli, T G Maddaford, Y J Chen, C D McPherson, S Jain and D Sontag
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1280-1291;

  15. Michel, J B

    1. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
      I Pham, W Gonzalez, A I el Amrani, M C Fournié-Zaluski, M Philippe, I Laboulandine, B P Roques and J B Michel
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1339-1347;

  16. Misicka, A

    1. Antinociceptive profile of biphalin, a dimeric enkephalin analog.
      P J Horan, A Mattia, E J Bilsky, S Weber, T P Davis, H I Yamamura, E Malatynska, S M Appleyard, J Slaninova and A Misicka
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1446-1454;

  17. Miyamoto, Y

    1. Involvement of delta 2 opioid receptors in acute dependence on morphine in mice.
      Y Miyamoto, P S Portoghese and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1325-1327;

  18. Molino, B F

    1. The gastrin/cholecystokinin-B receptor antagonist L-365,260 reduces basal acid secretion and prevents gastrointestinal damage induced by aspirin, ethanol and cysteamine in the rat.
      C E Pendley, L R Fitzpatrick, R W Ewing, B F Molino and G E Martin
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1348-1354;

  19. Moreland, R S

    1. Endothelin differentially affects rat gastric longitudinal and circular smooth muscle.
      J Fulginiti, M M Cohen and R S Moreland
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1413-1420;

  20. Mosqueda-Garcia, R

    1. Effects of nicotine on brain stem mechanisms of cardiovascular control.
      C J Tseng, M Appalsamy, D Robertson and R Mosqueda-Garcia
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1511-1518;

  21. Mulder, G J

    1. Stereoselectivity in glutathione conjugation and amidase-catalyzed hydrolysis of the 2-bromoisovalerylurea enantiomers in the single-pass perfused rat liver.
      M Polhuijs, I Gasinska, W F Cherry, G J Mulder and K S Pang
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1406-1412;

  22. Muller, B

    1. Characterization of indolidan- and rolipram-sensitive cyclic nucleotide phosphodiesterases in canine and human cardiac microsomal fractions.
      C Lugnier, B Muller, A Le Bec, C Beaudry and E Rousseau
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1142-1151;

N

  1. Nakajima, S

    1. Structure-activity relationship for D-ring derivatives of grayanotoxin in the squid giant axon.
      M Yakehiro, S Yamamoto, N Baba, S Nakajima, J Iwasa and I Seyama
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1328-1332;

  2. Nakazawa, M

    1. Putative, selective inhibitors of sarcoplasmic reticulum Ca+(+)-pump ATPase inhibit relaxation by nitroglycerin and atrial natriuretic factor of the rabbit aorta contracted by phenylephrine.
      D L Luo, M Nakazawa, T Ishibashi, K Kato and S Imai
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1187-1192;

  3. Napoli, K L

    1. Adrenochrome reaction implicates oxygen radicals in metabolism of cyclosporine A and FK-506 in rat and human liver microsomes.
      S S Ahmed, H W Strobel, K L Napoli and J Grevel
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1047-1054;

  4. Negus, S S

    1. Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats.
      S S Negus, S J Henriksen, A Mattox, G W Pasternak, P S Portoghese, A E Takemori, M B Weinger and G F Koob
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1245-1252;

  5. Nelson, D L

    1. Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines.
      D L Nelson, V L Lucaites, J E Audia, J S Nissen and D B Wainscott
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1272-1279;

  6. Nissen, J S

    1. Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines.
      D L Nelson, V L Lucaites, J E Audia, J S Nissen and D B Wainscott
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1272-1279;

  7. Norota, I

    1. On the mechanism of action of the beta-1 partial agonist denopamine in regulation of myocardial contractility: effects on myocardial alpha adrenoceptors and intracellular Ca++ transients.
      M Kohi, I Norota, M Takanashi and M Endoh
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1292-1300;

  8. Nowak, G

    1. Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid.
      G Nowak, R Trullas, R T Layer, P Skolnick and I A Paul
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1380-1386;

O

  1. O'Callaghan, J P

    1. Administration of 3,3'-iminodipropionitrile to the rat results in region-dependent damage to the central nervous system at levels above the brain stem.
      J Llorens, K M Crofton and J P O'Callaghan
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1492-1498;

  2. Ogonowski, A A

    1. The oral antihypertensive activity of the methylated derivatives of phenyl-2-aminoethyl sulfide.
      S H Pollock, M I Reichbaum, J C Colbert, P A Husain, J M Holbrook, A A Ogonowski, J S Khlief and S W May
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1113-1117;

  3. Okada, Y

    1. Ionic mechanism of minoxidil sulfate-induced shortening of action potential durations in guinea pig ventricular myocytes.
      S Hayashi, M Horie and Y Okada
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1527-1533;

  4. Owens, S M

    1. Dose- and time-dependent changes in phencyclidine metabolite covalent binding in rats and the possible role of CYP2D1.
      S M Owens, M Gunnell, E M Laurenzana and J L Valentine
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1261-1266;

P

  1. Padbury, J F

    1. Dobutamine pharmacokinetics and pharmacodynamics in normal children and adolescents.
      R A Berg, J F Padbury, R L Donnerstein, S E Klewer and J J Hutter
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1232-1238;

  2. Pang, K S

    1. Stereoselectivity in glutathione conjugation and amidase-catalyzed hydrolysis of the 2-bromoisovalerylurea enantiomers in the single-pass perfused rat liver.
      M Polhuijs, I Gasinska, W F Cherry, G J Mulder and K S Pang
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1406-1412;
    2. Kinetics of sequential metabolism. I. Formation and metabolism of oxazepam from nordiazepam and temazepam in the perfused murine liver.
      M V St-Pierre and K S Pang
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1429-1436;
    3. Kinetics of sequential metabolism. II. Formation and metabolism of nordiazepam and oxazepam from diazepam in the perfused murine liver.
      M V St-Pierre and K S Pang
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1437-1445;

  3. Pasternak, G W

    1. Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats.
      S S Negus, S J Henriksen, A Mattox, G W Pasternak, P S Portoghese, A E Takemori, M B Weinger and G F Koob
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1245-1252;

  4. Paul, I A

    1. Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid.
      G Nowak, R Trullas, R T Layer, P Skolnick and I A Paul
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1380-1386;

  5. Pendley, C E

    1. The gastrin/cholecystokinin-B receptor antagonist L-365,260 reduces basal acid secretion and prevents gastrointestinal damage induced by aspirin, ethanol and cysteamine in the rat.
      C E Pendley, L R Fitzpatrick, R W Ewing, B F Molino and G E Martin
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1348-1354;

  6. Pereira, E F

    1. Identification and functional characterization of a new agonist site on nicotinic acetylcholine receptors of cultured hippocampal neurons.
      E F Pereira, S Reinhardt-Maelicke, A Schrattenholz, A Maelicke and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1474-1491;

  7. Pham, I

    1. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
      I Pham, W Gonzalez, A I el Amrani, M C Fournié-Zaluski, M Philippe, I Laboulandine, B P Roques and J B Michel
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1339-1347;

  8. Philippe, M

    1. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
      I Pham, W Gonzalez, A I el Amrani, M C Fournié-Zaluski, M Philippe, I Laboulandine, B P Roques and J B Michel
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1339-1347;

  9. Pierce, G N

    1. Modulation of cardiac performance by amiloride and several selected derivatives of amiloride.
      G N Pierce, W C Cole, K Liu, H Massaeli, T G Maddaford, Y J Chen, C D McPherson, S Jain and D Sontag
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1280-1291;

  10. Polhuijs, M

    1. Stereoselectivity in glutathione conjugation and amidase-catalyzed hydrolysis of the 2-bromoisovalerylurea enantiomers in the single-pass perfused rat liver.
      M Polhuijs, I Gasinska, W F Cherry, G J Mulder and K S Pang
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1406-1412;

  11. Pollock, S H

    1. The oral antihypertensive activity of the methylated derivatives of phenyl-2-aminoethyl sulfide.
      S H Pollock, M I Reichbaum, J C Colbert, P A Husain, J M Holbrook, A A Ogonowski, J S Khlief and S W May
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1113-1117;

  12. Portoghese, P S

    1. Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats.
      S S Negus, S J Henriksen, A Mattox, G W Pasternak, P S Portoghese, A E Takemori, M B Weinger and G F Koob
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1245-1252;
    2. Involvement of delta 2 opioid receptors in acute dependence on morphine in mice.
      Y Miyamoto, P S Portoghese and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1325-1327;

  13. Poulsen, H E

    1. N-acetylcysteine inhibits angiotensin converting enzyme in vivo.
      S Boesgaard, J Aldershvile, H E Poulsen, S Christensen, H Dige-Petersen and J Giese
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1239-1244;

  14. Price, W A

    1. Pharmacology of 2-amino-1,4-dihydro-4-(2-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butylsulfinyl]phenyl)-6-methyl-5-nitro-3-pyridine carboxylic acid methyl ester (XB513), a novel calcium agonist with alpha-1 adrenergic receptor antagonistic.
      P C Wong, P E Aldrich, A T Chiu, R A Earl, S D Hart, A L Johnson, P Ma, D E McCall, W A Price and R D Smith
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1088-1095;

R

  1. Rampe, D

    1. Comparison of the in vitro and in vivo cardiovascular effects of two structurally distinct Ca++ channel activators, BAY K 8644 and FPL 64176.
      D Rampe, B Anderson, V Rapien-Pryor, T Li and R C Dage
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1125-1130;

  2. Rapien-Pryor, V

    1. Comparison of the in vitro and in vivo cardiovascular effects of two structurally distinct Ca++ channel activators, BAY K 8644 and FPL 64176.
      D Rampe, B Anderson, V Rapien-Pryor, T Li and R C Dage
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1125-1130;

  3. Ravindranath, V

    1. Oxidative stress and thiol modification induced by chronic administration of haloperidol.
      B R Shivakumar and V Ravindranath
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1137-1141;

  4. Reeves, M L

    1. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle.
      T J Torphy, B J Undem, L B Cieslinski, M A Luttmann, M L Reeves and D W Hay
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1213-1223;

  5. Reichbaum, M I

    1. The oral antihypertensive activity of the methylated derivatives of phenyl-2-aminoethyl sulfide.
      S H Pollock, M I Reichbaum, J C Colbert, P A Husain, J M Holbrook, A A Ogonowski, J S Khlief and S W May
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1113-1117;

  6. Reinhardt-Maelicke, S

    1. Identification and functional characterization of a new agonist site on nicotinic acetylcholine receptors of cultured hippocampal neurons.
      E F Pereira, S Reinhardt-Maelicke, A Schrattenholz, A Maelicke and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1474-1491;

  7. Roache, J D

    1. Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: antagonism and precipitated withdrawal.
      R R Griffiths, S M Evans, J J Guarino, J D Roache, W R Furman, I Liebson and E M Schwam
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1163-1174;

  8. Robertson, D

    1. Effects of nicotine on brain stem mechanisms of cardiovascular control.
      C J Tseng, M Appalsamy, D Robertson and R Mosqueda-Garcia
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1511-1518;

  9. Robertson, L W

    1. Effect of genetic obesity and phenobarbital treatment on the hepatic conjugation pathways.
      I P Chaudhary, S Tuntaterdtum, P J McNamara, L W Robertson and R A Blouin
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1333-1338;

  10. Rodeheaver, D P

    1. Extracellular acidosis ameliorates metabolic-inhibitor-induced and potentiates oxidant-induced cell death in renal proximal tubules.
      D P Rodeheaver and R G Schnellmann
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1355-1360;

  11. Roques, B P

    1. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
      I Pham, W Gonzalez, A I el Amrani, M C Fournié-Zaluski, M Philippe, I Laboulandine, B P Roques and J B Michel
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1339-1347;

  12. Rosenzweig-Lipson, S

    1. Modification of the behavioral effects of the selective dopamine D2 agonist (+)-4-propyl-9-hydroxynaphthoxazine by dopamine antagonists in monkeys.
      S Rosenzweig-Lipson and J Bergman
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1039-1046;

  13. Rousseau, E

    1. Characterization of indolidan- and rolipram-sensitive cyclic nucleotide phosphodiesterases in canine and human cardiac microsomal fractions.
      C Lugnier, B Muller, A Le Bec, C Beaudry and E Rousseau
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1142-1151;

  14. Rutter, J J

    1. Acute uptake inhibition increases extracellular serotonin in the rat forebrain.
      J J Rutter and S B Auerbach
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1319-1324;

S

  1. Salazar, L A

    1. Quantitative analysis of concentration-response curves for precipitated abstinence responses in the opiate-dependent guinea pig ileum.
      S L Cruz, L A Salazar, A Fernández-Guasti and J E Villarreal
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1519-1526;

  2. Sathirakul, K

    1. Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats.
      K Sathirakul, H Suzuki, K Yasuda, M Hanano, O Tagaya, T Horie and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1301-1312;

  3. Schachter, M

    1. Ion channel involvement in the acute vascular effects of thiazide diuretics and related compounds.
      J A Calder, M Schachter and P S Sever
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1175-1180;

  4. Schnellmann, R G

    1. Extracellular acidosis ameliorates metabolic-inhibitor-induced and potentiates oxidant-induced cell death in renal proximal tubules.
      D P Rodeheaver and R G Schnellmann
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1355-1360;

  5. Schrattenholz, A

    1. Identification and functional characterization of a new agonist site on nicotinic acetylcholine receptors of cultured hippocampal neurons.
      E F Pereira, S Reinhardt-Maelicke, A Schrattenholz, A Maelicke and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1474-1491;

  6. Schwam, E M

    1. Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: antagonism and precipitated withdrawal.
      R R Griffiths, S M Evans, J J Guarino, J D Roache, W R Furman, I Liebson and E M Schwam
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1163-1174;

  7. Sever, P S

    1. Ion channel involvement in the acute vascular effects of thiazide diuretics and related compounds.
      J A Calder, M Schachter and P S Sever
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1175-1180;

  8. Seyama, I

    1. Structure-activity relationship for D-ring derivatives of grayanotoxin in the squid giant axon.
      M Yakehiro, S Yamamoto, N Baba, S Nakajima, J Iwasa and I Seyama
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1328-1332;

  9. Shaffer, J E

    1. The inotropic and beta blocking effects of a chimeric molecule that putatively inhibits both type III phosphodiesterase and beta adrenoceptors in anesthetized dogs.
      J E Shaffer, M K Grizzle, D K Anderson and T N Wheeler
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1105-1112;

  10. Sheng, J

    1. Relative potency and efficacy of some dopamine agonists with varying selectivities for D1 and D2 receptors in MPTP-induced hemiparkinsonian monkeys.
      E F Domino and J Sheng
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1387-1391;

  11. Shivakumar, B R

    1. Oxidative stress and thiol modification induced by chronic administration of haloperidol.
      B R Shivakumar and V Ravindranath
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1137-1141;

  12. Skolnick, P

    1. Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid.
      G Nowak, R Trullas, R T Layer, P Skolnick and I A Paul
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1380-1386;
    2. Neurochemical actions of inhalational anesthetics at the GABAA receptor complex.
      B Harris, G Wong and P Skolnick
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1392-1398;

  13. Slaninova, J

    1. Antinociceptive profile of biphalin, a dimeric enkephalin analog.
      P J Horan, A Mattia, E J Bilsky, S Weber, T P Davis, H I Yamamura, E Malatynska, S M Appleyard, J Slaninova and A Misicka
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1446-1454;

  14. Slawsky, M T

    1. Characterization of 4-aminopyridine block of the transient outward K+ current in adult rat ventricular myocytes.
      N A Castle and M T Slawsky
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1450-1459;

  15. Sloan, J W

    1. Effect of the chronic dose of diazepam on the intensity and characteristics of the precipitated abstinence syndrome in the dog.
      J W Sloan, W R Martin and E Wala
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1152-1162;

  16. Smith, R D

    1. Pharmacology of 2-amino-1,4-dihydro-4-(2-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butylsulfinyl]phenyl)-6-methyl-5-nitro-3-pyridine carboxylic acid methyl ester (XB513), a novel calcium agonist with alpha-1 adrenergic receptor antagonistic.
      P C Wong, P E Aldrich, A T Chiu, R A Earl, S D Hart, A L Johnson, P Ma, D E McCall, W A Price and R D Smith
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1088-1095;

  17. Sontag, D

    1. Modulation of cardiac performance by amiloride and several selected derivatives of amiloride.
      G N Pierce, W C Cole, K Liu, H Massaeli, T G Maddaford, Y J Chen, C D McPherson, S Jain and D Sontag
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1280-1291;

  18. Srimal, R C

    1. Pulmonary thromboembolism-induced alterations in nitric oxide release from rat circulating neutrophils.
      M Dikshit, R Kumari and R C Srimal
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1369-1373;

  19. St-Pierre, M V

    1. Kinetics of sequential metabolism. I. Formation and metabolism of oxazepam from nordiazepam and temazepam in the perfused murine liver.
      M V St-Pierre and K S Pang
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1429-1436;
    2. Kinetics of sequential metabolism. II. Formation and metabolism of nordiazepam and oxazepam from diazepam in the perfused murine liver.
      M V St-Pierre and K S Pang
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1437-1445;

  20. Statkevich, P

    1. Characterization of methotrexate elimination and interaction with indomethacin and flurbiprofen in the isolated perfused rat kidney.
      P Statkevich, D J Fournier and K R Sweeney
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1118-1124;

  21. Steppuhn, K G

    1. Modulation of the seizure threshold for excitatory amino acids in mice by antiepileptic drugs and chemoconvulsants.
      K G Steppuhn and L Turski
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1063-1070;

  22. Strobel, H W

    1. Adrenochrome reaction implicates oxygen radicals in metabolism of cyclosporine A and FK-506 in rat and human liver microsomes.
      S S Ahmed, H W Strobel, K L Napoli and J Grevel
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1047-1054;

  23. Sugiyama, Y

    1. Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats.
      K Sathirakul, H Suzuki, K Yasuda, M Hanano, O Tagaya, T Horie and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1301-1312;

  24. Suzuki, H

    1. Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats.
      K Sathirakul, H Suzuki, K Yasuda, M Hanano, O Tagaya, T Horie and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1301-1312;

  25. Sweeney, K R

    1. Characterization of methotrexate elimination and interaction with indomethacin and flurbiprofen in the isolated perfused rat kidney.
      P Statkevich, D J Fournier and K R Sweeney
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1118-1124;

T

  1. Tagaya, O

    1. Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats.
      K Sathirakul, H Suzuki, K Yasuda, M Hanano, O Tagaya, T Horie and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1301-1312;

  2. Takanashi, M

    1. On the mechanism of action of the beta-1 partial agonist denopamine in regulation of myocardial contractility: effects on myocardial alpha adrenoceptors and intracellular Ca++ transients.
      M Kohi, I Norota, M Takanashi and M Endoh
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1292-1300;

  3. Takemori, A E

    1. Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats.
      S S Negus, S J Henriksen, A Mattox, G W Pasternak, P S Portoghese, A E Takemori, M B Weinger and G F Koob
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1245-1252;
    2. Involvement of delta 2 opioid receptors in acute dependence on morphine in mice.
      Y Miyamoto, P S Portoghese and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1325-1327;

  4. Torphy, T J

    1. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle.
      T J Torphy, B J Undem, L B Cieslinski, M A Luttmann, M L Reeves and D W Hay
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1213-1223;

  5. Trullas, R

    1. Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid.
      G Nowak, R Trullas, R T Layer, P Skolnick and I A Paul
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1380-1386;

  6. Tseng, C J

    1. Effects of nicotine on brain stem mechanisms of cardiovascular control.
      C J Tseng, M Appalsamy, D Robertson and R Mosqueda-Garcia
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1511-1518;

  7. Tuntaterdtum, S

    1. Effect of genetic obesity and phenobarbital treatment on the hepatic conjugation pathways.
      I P Chaudhary, S Tuntaterdtum, P J McNamara, L W Robertson and R A Blouin
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1333-1338;

  8. Turski, L

    1. Modulation of the seizure threshold for excitatory amino acids in mice by antiepileptic drugs and chemoconvulsants.
      K G Steppuhn and L Turski
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1063-1070;

U

  1. Undem, B J

    1. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle.
      T J Torphy, B J Undem, L B Cieslinski, M A Luttmann, M L Reeves and D W Hay
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1213-1223;

V

  1. Valentine, J L

    1. Dose- and time-dependent changes in phencyclidine metabolite covalent binding in rats and the possible role of CYP2D1.
      S M Owens, M Gunnell, E M Laurenzana and J L Valentine
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1261-1266;

  2. Vandermeersch, S

    1. Intrinsic properties of the nonpeptide angiotensin II antagonist losartan in glomeruli and mesangial cells at high concentrations.
      D Chansel, L Badre, S Czekalski, S Vandermeersch, J Cambar and R Ardaillou
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1534-1543;

  3. van Rijn, H J

    1. Indomethacin- and desamino-8-D-arginine vasopressin-induced lithium reabsorption is not amiloride sensitive in humans.
      J A Bijlsma, H A Koomans, W H Boer, E J Dorhout Mees and H J van Rijn
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1267-1271;

  4. Varma, D R

    1. Endothelium- and beta-2 adrenoceptor-independent relaxation of rat aorta by tyramine and certain other phenylethylamines.
      D R Varma and S Chemtob
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1096-1104;

  5. Villarreal, J E

    1. Quantitative analysis of concentration-response curves for precipitated abstinence responses in the opiate-dependent guinea pig ileum.
      S L Cruz, L A Salazar, A Fernández-Guasti and J E Villarreal
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1519-1526;

W

  1. Wainscott, D B

    1. Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines.
      D L Nelson, V L Lucaites, J E Audia, J S Nissen and D B Wainscott
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1272-1279;

  2. Wala, E

    1. Effect of the chronic dose of diazepam on the intensity and characteristics of the precipitated abstinence syndrome in the dog.
      J W Sloan, W R Martin and E Wala
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1152-1162;

  3. Wang, F S

    1. Pentobarbital administered intracerebroventricularly antagonizes morphine-induced antinociception in mice.
      F S Wang and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1361-1368;

  4. Watanabe, K

    1. Inhibition of gastric acid secretion in vivo and in vitro by an inhibitor of Cl(-)-HCO3- exchanger, 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid.
      S Horie, S Yano and K Watanabe
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1313-1318;

  5. Watts, V J

    1. Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone.
      D T Lysle, M E Coussons, V J Watts, E H Bennett and L A Dykstra
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1071-1078;

  6. Weber, S

    1. Antinociceptive profile of biphalin, a dimeric enkephalin analog.
      P J Horan, A Mattia, E J Bilsky, S Weber, T P Davis, H I Yamamura, E Malatynska, S M Appleyard, J Slaninova and A Misicka
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1446-1454;

  7. Weinger, M B

    1. Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats.
      S S Negus, S J Henriksen, A Mattox, G W Pasternak, P S Portoghese, A E Takemori, M B Weinger and G F Koob
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1245-1252;

  8. Wheeler, T N

    1. The inotropic and beta blocking effects of a chimeric molecule that putatively inhibits both type III phosphodiesterase and beta adrenoceptors in anesthetized dogs.
      J E Shaffer, M K Grizzle, D K Anderson and T N Wheeler
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1105-1112;

  9. White, D A

    1. Acute effects of calcitonin gene-related peptide on the mechanical and electrical responses of the rat hemidiaphragm.
      N W Fleming, B K Lewis, D A White and K L Dretchen
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1199-1204;

  10. Willetts, J

    1. Behavioral pharmacology of NPC 17742, a competitive N-methyl-D-aspartate (NMDA) antagonist.
      J Willetts, D B Clissold, T L Hartman, R R Brandsgaard, G S Hamilton and J W Ferkany
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1055-1062;

  11. Winer, N

    1. Progesterone and mifepristone modify principally the responses of circular myometrium to oxytocin in preparturient rats: comparison with responses to acetylcholine and to calcium.
      A el Alj, N Winer, H Lallaoui, R Delansorne, F Ferre and G Germain
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1205-1212;

  12. Wong, G

    1. Neurochemical actions of inhalational anesthetics at the GABAA receptor complex.
      B Harris, G Wong and P Skolnick
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1392-1398;

  13. Wong, P C

    1. Pharmacology of 2-amino-1,4-dihydro-4-(2-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butylsulfinyl]phenyl)-6-methyl-5-nitro-3-pyridine carboxylic acid methyl ester (XB513), a novel calcium agonist with alpha-1 adrenergic receptor antagonistic.
      P C Wong, P E Aldrich, A T Chiu, R A Earl, S D Hart, A L Johnson, P Ma, D E McCall, W A Price and R D Smith
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1088-1095;

Y

  1. Yakehiro, M

    1. Structure-activity relationship for D-ring derivatives of grayanotoxin in the squid giant axon.
      M Yakehiro, S Yamamoto, N Baba, S Nakajima, J Iwasa and I Seyama
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1328-1332;

  2. Yamamoto, S

    1. Structure-activity relationship for D-ring derivatives of grayanotoxin in the squid giant axon.
      M Yakehiro, S Yamamoto, N Baba, S Nakajima, J Iwasa and I Seyama
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1328-1332;

  3. Yamamura, H I

    1. Antinociceptive profile of biphalin, a dimeric enkephalin analog.
      P J Horan, A Mattia, E J Bilsky, S Weber, T P Davis, H I Yamamura, E Malatynska, S M Appleyard, J Slaninova and A Misicka
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1446-1454;

  4. Yano, S

    1. Inhibition of gastric acid secretion in vivo and in vitro by an inhibitor of Cl(-)-HCO3- exchanger, 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid.
      S Horie, S Yano and K Watanabe
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1313-1318;

  5. Yasuda, K

    1. Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats.
      K Sathirakul, H Suzuki, K Yasuda, M Hanano, O Tagaya, T Horie and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1301-1312;

Z

  1. Zeidel, M L

    1. Differential actions of cisplatin on renal proximal tubule and inner medullary collecting duct cells.
      H R Brady, M L Zeidel, B C Kone, G Giebisch and S R Gullans
      Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1421-1428;
Back to top

In this issue